| |
| May 09, 2013 |
Sernova Provides Corporate Update and Results of 2013 Annual General Meeting |
| March 25, 2013 |
Sernova Awarded Funding to Optimize its Sertolin(TM) Local Therapeutic Cell Anti-Rejection Technology for the Treatment of Chronic Diseases |
| February 28, 2013 |
Sernova and Centre for Commercialization of Regenerative Medicine Partner To Treat Chronic Diseases |
| February 19, 2013 |
Sernova Completes Non-Brokered Private Placement |
| January 21, 2013 |
Sernova Announces Non-Brokered Private Placement |
| December 03, 2012 |
Sernova's Novel Method Evaluates Islets Prior to Transplantation and Predicts Their Ability to Reverse Diabetes Post Transplantation |
| September 04, 2012 |
Sernova to Present at Rodman & Renshaw Annual Global Investment Conference |
| August 16, 2012 |
World First - Islet Transplant Into Man Using Sernova's Cell Pouch(TM) For Treatment Of Diabetes |
| June 06, 2012 |
Sernova Announces Exercise of Warrants |
| May 02, 2012 |
Sernova Receives Health Canada Approval to Initiate Human Clinical Trials of its Cell Pouch (TM) |
| |
